Heron Therapeutics: Q4 Earnings Insights

Heron Therapeutics HRTX reported its Q4 earnings results on Tuesday, March 12, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Heron Therapeutics beat estimated earnings by 56.00000000000001%, reporting an EPS of $-0.07 versus an estimate of $-0.16.

Revenue was up $4.21 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.12 which was followed by a 59.0% increase in the share price the next day.

Here's a look at Heron Therapeutics's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.29 -0.23 -0.20 -0.28
EPS Actual -0.17 -0.35 -0.27 -0.17
Revenue Estimate 32.75M 31.70M 29.69M 26.90M
Revenue Actual 31.43M 31.76M 29.61M 30.03M

To track all earnings releases for Heron Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!